Special Issue "Parkinson’s Disease (PD): Molecular Mechanisms and Novel Treatment Strategies"
Deadline for manuscript submissions: closed (25 February 2023) | Viewed by 35834
Interests: Parkinson’s disease pathogenesis; neurodegeneration; stem cells; dopaminergic differentiation; neurotrophic factors; neuroprotection; cell replacement therpy; bioimaging; regenerative medicin
Special Issues, Collections and Topics in MDPI journals
Interests: Parkinson’s disease pathogenesis; stem cells; dopaminergic differentiation; neurodegeneration; neuroprotection; neurotrophic factors; bioimaging; cell replacement therapy; regenerative medicine
In 2021, more than two centuries after its initial description, Parkinson’s disease (PD) is still a topic of intense research. Despite significant progress in the management of its motor symptoms by pharmacologic dopamine replacement therapy or advanced deep brain stimulation, there is still no cure, and all attempts to develop treatments that halt or slow down the ruthless progression of the disease have failed. Ironically, it is mainly the improved management of motor symptoms that have made us aware of the devastating impact of non-motor symptoms, including autonomic dysfunction, depression, pain, and cognitive decline. A better understanding of the complex molecular and cellular pathogenic mechanisms that contribute to disease and the development of late complications is therefore urgently needed in order to develop novel preventive or efficient disease-modifying therapies. The present Special Issue of Cells aims to summarize and highlight a) some of the latest advances in our understanding of PD and b) innovative therapeutic strategies as potential approaches useful to implement scientific heritage in this field. For this purpose, we are encouraging basic and clinical researchers to present their valuable work as a scientific contribution or review articles. We will really appreciate your contribution, and it will be a pleasure for us to receive your manuscripts.
Prof. Morten Meyer
Dr. Justyna Okarmus
Assistant Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Parkinson’s disease pathogenesis
- alpha-synuclein pathology
- stem cells
- disease modelling
- growth factors
- gene therapy
- cell transplantation
- deep brain stimulation
- focussed ultrasound
- pharmacological treatment